COVID-19
-
Futuristic coating for hospital fabrics and activewear kills COVID and E. coli
UBC researchers have developed an inexpensive, non-toxic coating for almost any fabric that decreases the infectivity of the virus that causes COVID-19 by up to 90 per cent.
-
Your Google symptom searches could improve COVID modelling
Adding Google searches for symptoms and other information to COVID forecast models increased their accuracy, recent UBC research has found.
-
Machine learning and AI used to rapidly detect sepsis, cutting risk of death dramatically
A groundbreaking advance in quickly detecting sepsis using machine learning has been pioneered by researchers in the Hancock Lab and the department of microbiology and immunology at UBC.
-
UBC clinical trial supports new self-administered rapid antigen test
Thanks to new research compiled with data from UBC’s first on-campus clinical study, a new self-administered rapid antigen test will soon be available in Canada. It's a tool that could help combat growing uncertainty, prevent transmission and potentially save lives.
-
COVID-19: Planning for 2021/22 Winter Session, Term 2
As we approach Winter Session Term 2 in January, we would like to update you on recent discussions around COVID-19 and the emergence of the Omicron variant.
-
UBC scientists unveil world’s first molecular-level analysis of Omicron variant spike protein
UBC researchers are the first in the world to conduct a molecular-level structural analysis of the Omicron variant spike protein.
-
Statement regarding health and safety during exams
Throughout the pandemic, UBC has worked closely with the Provincial Health Officer and Regional Health Authorities to ensure we are following their guidance in our campus operations and that we are keeping our community safe.
-
Spread cheer, not COVID: Tips for staying safe this holiday season
Devon Greyson, assistant professor at UBC’s school of population and public health, answers some common questions about how to stay safe and healthy this holiday season.
-
Delaying second dose of mRNA COVID-19 vaccine produces stronger immune response
The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response.